|
2006 |
2005 |
| Earnings per share (basic) [USD] |
1.72 |
0.72 |
| Cash earnings per share (CEPS) [USD] |
-3.49 |
1.33 |
| Return on capital employed (ROCE) [%] |
14.6% |
6.5% |
| Return on equity (ROE) [%] |
12.3% |
5.5% |
| Debt/equity ratio [%] |
0.9 |
1.2 |
| Net Debt/EBITDA |
2.5 |
3.9 |
| Net interest coverage |
6.3 |
2.7 |
| Equity per share [USD] |
15.81 |
10.47 |
| Operating margin [% of sales] |
10.4% |
9.0% |
| EBITDA margin |
18.1% |
14.9% |
| Net margin |
5.8% |
2.7% |
| Capital expenditure* (acquisitions of [USD million] |
24 903 |
96 373 |
| Capital expenditure [% of sales] |
6.6% |
42.0% |
| Capital employed [USD million] |
237 725 |
271 678 |
| Interest-bearing net liabilities [USD million] |
187 824 |
168 581 |
| Average number of employees |
5 082 |
4 396 |
| Average number of shares [million] periodic |
13 750 000 |
13 750 000 |
| Average number of shares [million] cumulative |
13 750 000 |
13 750 000 |
| * Acquisition of property. plant and equipment. biological assets and subsidiaries |